Canadian Journal of Kidney Health and Disease, published by SAGE Publications Inc, is a leading open-access journal dedicated to advancing the field of nephrology. Established in 2014, the journal aims to bridge the gap between research and clinical practice by disseminating high-quality clinical and experimental research findings, reviews, and case studies that focus on kidney health and associated disorders. With an impressive impact factor and ranked in the Q2 category for nephrology, the journal fosters an environment for interdisciplinary collaboration and innovation, enhancing the visibility of crucial advancements in kidney disease research. As an open-access journal, it ensures that valuable knowledge is accessible to researchers, healthcare professionals, and students globally, facilitating a deeper understanding of kidney health issues and promoting improved patient care. Located in the United Kingdom, the journal continues to expand its reach and influence within the nephrology community, leveraging its open-access model to encourage a diverse audience in exploring cutting-edge findings and sharing insights pertinent to kidney health.

The Journal of Renal Care, published by Wiley, stands as a leading scholarly platform for researchers, healthcare professionals, and students dedicated to advancements in nephrology and specialized nursing practices. With an impact factor that reflects its high degree of influence in the field—ranking in the Q1 category for Advanced and Specialized Nursing and Q2 for Nephrology based on 2023 metrics—it serves as an essential resource for innovative research and clinical insights. The journal's ISSN (1755-6678) and E-ISSN (1755-6686) facilitate easy access to cutting-edge studies and reviews that have shaped the scope of renal care since its inception in 2006, with a converged publication span extending until 2024. Addressing the pressing challenges within nephrology, this journal fosters a stimulating academic environment, enhancing the quality of patient care through rigorous peer-reviewed research and dialogue. As it continues to contribute significantly to both nursing and medical disciplines, the Journal of Renal Care remains a pivotal source for nurturing knowledge and advancing practice in renal healthcare.

Kidney International Supplements is a prestigious academic journal published by Elsevier Science Inc, specializing in the field of nephrology. With an impressive impact factor and ranked in the top percentile, it holds the esteemed position of Q1 in nephrology categories, reflecting its influential contribution to the academic community. Throughout its publication history from 2011 to 2022 and in the anticipated 2024 edition, the journal has provided a vital platform for disseminating high-quality research and insights, catering to professionals, researchers, and students dedicated to advancing kidney health. While it offers traditional access options, the journal is committed to promoting the highest standards of research integrity and innovation in nephrology. The journal plays an essential role in shaping the future of kidney disease treatment, levelling knowledge exchange across specialties, and fostering collaboration among experts in the field.

Nephrologie & Therapeutique is a distinguished peer-reviewed journal published by JOHN LIBBEY EUROTEXT LTD, dedicated to the field of nephrology. Since its inception in 2005, this journal has been pivotal in disseminating high-quality research in the areas of kidney disease, renal therapies, and nephrological advancements, and it continues to serve as an essential resource for professionals, researchers, and students alike. With an ISSN of 1769-7255 and an E-ISSN of 1872-9177, the journal is indexed in Scopus and is currently ranked in the third quartile (Q3) within the nephrology category, showing significant contributions to the discipline, despite its current ranking of 64 out of 81. Although Nephrologie & Therapeutique does not operate under an open access model, it nevertheless provides valuable insights and updates on the latest findings and practices in nephrology, making it an important platform for academic discourse in this field. The journal's commitment to advancing knowledge and fostering interdisciplinary dialogue underscores its role as a key player in shaping future research and clinical practices in nephrology.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

CLINICAL NEPHROLOGY is a prestigious academic journal dedicated to advancing the field of nephrology and related areas of medicine. Published by DUSTRI-VERLAG DR KARL FEISTLE, this journal has been a critical resource for researchers and practitioners since its inception in 1973, with a commitment to disseminating high-quality, peer-reviewed articles that provide insights into clinical practices, innovative treatments, and emerging research in kidney diseases. With an ISSN of 0301-0430, CLINICAL NEPHROLOGY stands out in the medical community, achieving a commendable Q3 ranking in both general medicine and nephrology fields as of 2023. The journal's focus on both clinical application and rigorous scientific inquiry makes it an essential read for healthcare professionals and researchers looking to stay at the forefront of nephrology advancements. Although it operates under a subscription model, its broad scope promises invaluable contributions that address practical challenges and foster interdisciplinary dialogue within the healthcare landscape.

The American Journal of Nephrology, published by KARGER, stands as a prestigious platform for the dissemination of high-quality research in the field of nephrology, boasting an impressive Q1 ranking in its category as of 2023. With its ISSN 0250-8095 and E-ISSN 1421-9670, the journal has been committed to advancing knowledge in kidney diseases since its inception in 1981. It serves as an essential resource for researchers, clinicians, and students alike, featuring original articles, reviews, and case reports that contribute to the understanding and treatment of renal conditions. Despite not being an open-access journal, the American Journal of Nephrology ensures a rigorous peer-review process to maintain its high academic standards, making it a vital source of information for the nephrology community worldwide. By providing insights into emerging trends and breakthroughs in kidney health, the journal continues to play a crucial role in shaping the future of nephrology research.

Turkish Journal of Nephrology, published by AVES, serves as a pivotal platform for disseminating significant research in the domains of nephrology, transplantation, and surgery. Since its establishment as an Open Access journal in 2019, it has gained traction for delivering high-quality, peer-reviewed articles that reflect the latest advancements and practices in these critical medical fields. Based in Turkey, this journal has rapidly become an important resource, particularly for researchers and healthcare professionals striving to enhance kidney healthcare strategies. Despite being categorized in the fourth quartile across its main categories for 2023 and having modest rankings within Scopus, its commitment to openness and accessibility fosters a collaborative academic environment that promotes knowledge sharing. We encourage scholars, practitioners, and students to engage with the journal's content to further drive innovation and improve patient outcomes in nephrology and associated disciplines.

ADVANCES IN CHRONIC KIDNEY DISEASE is a pivotal journal in the field of nephrology, published by W B Saunders Co-Elsevier Inc., that has been influential in disseminating cutting-edge research from 2004 until 2022. With an impact factor reflecting its esteem in the academic community and a commendable Q2 ranking within the category of Nephrology, this journal is recognized for its contribution to advancing the understanding of chronic kidney disease. Although the journal's coverage in Scopus has been discontinued, it maintains a key position, holding the 13th rank out of 70 in the Nephrology medicine classification, showcasing its prominent percentile of 82. Subscribers to the journal can look forward to a repository of high-quality articles and reviews that explore novel therapeutic approaches, epidemiological studies, and potential biomarkers in chronic kidney disease, making it a vital resource for researchers, professionals, and students striving to enhance their knowledge and practice in nephrology. For more information on accessing issues or viewing title changes, please refer to the journal's official page.

Clinical and Experimental Nephrology, published by SPRINGER, serves as a crucial platform for researchers and practitioners in the field of nephrology. With its roots dating back to 1999, the journal has made significant strides in exploring various dimensions of kidney health, thereby enriching our understanding of nephrological diseases. Aimed at fostering interdisciplinary dialogue, it covers a broad spectrum of topics from clinical practices to experimental research, evidenced by its ranked quartiles of Q2 in Nephrology and Q3 in both Physiology and Medical Physiology within its latest evaluation. Although not open access, the journal's rigorous peer-review process ensures the publication of high-quality research, making it a valuable resource for professionals, academic institutions, and students. The journal is located in Japan, with its editorial office situated at One New York Plaza, Suite 4600, New York, NY 10004, United States, reflecting its global influence and intent to disseminate critical findings in nephrology and beyond.